RYZB - RayzeBio, Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RayzeBio, Common Stock's activity chart (see below) currently has 2 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 73 days.

Most recent stock forecast was given by from JPMORGAN on 28-Dec-2023. First documented stock forecast 10-Oct-2023.

Jessica Fye Robyn Karnauskas

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Oct-2023

$30

2 years 8 months 25 days ago
(28-Dec-2023)

1/1 (100%)

$10 (50.00%)

Buy Since 10-Oct-2023

$29

2 years 8 months 26 days ago
(27-Dec-2023)

1/1 (100%)

$9 (45.00%)

Show more analysts

What is RYZB (RayzeBio, Common Stock) average time for price targets to be met?

On average it took 73 days for the stock forecasts to be reached, with an average price target met ratio of 100%.

Which analyst most recently updated their price target on RYZB (RayzeBio, Common Stock)?

Which analyst has the most public recommendations on RYZB (RayzeBio, Common Stock)?

has 0 price targets and 0 ratings on RYZB

Which analyst is the currently most bullish on RYZB (RayzeBio, Common Stock)?

Robyn Karnauskas with the highest potential upside of $0

Which analyst is the currently most reserved on RYZB (RayzeBio, Common Stock)?

Jessica Fye with the lowest potential downside of -$0